Announced today that lorcaserin will be highlighted in multiple presentations at Obesity 2009.

Arena Pharmaceuticals to present Stage 3 BLOSSOM trial outcomes at Obesity 2009 Arena Pharmaceuticals, Inc. announced today that lorcaserin will be highlighted in multiple presentations at Obesity 2009, the 27th Annual Scientific Meeting of The Obesity Society in Washington, DC. The line-up carries a late-breaking abstract oral presentation of outcomes from BLOSSOM , a Phase 3 trial for which Arena reported positive, in September highly significant top-line results. Arena may also present brand-new data analyses from lorcaserin’s successful Phase 3 pivotal program in oral and poster classes.He mentioned reviews of veterans’ groups going to the Boston Marathon survivors in a healthcare facility, just to speak to patients to tell them there is lifestyle after amputation. It’s up to a person concerning how they accept their brand-new body and how associates of their family connect to them and sort out it, Wynne stated. Hospitals quick to put into action lessons from Boston, but financing a concern Doctors describe horrors, chaos after Boston Marathon bombings Anxiety is regular, but PTSD might simmer in kids who’ve seen Boston Marathon bombing What both prosthetists emphasized was that losing a limb didn’t mean that you’ll no longer have the ability to appreciate what you have been used to doing.

Other entries from category "laboratory":

Random entries